A

AstraZeneca PLC
NASDAQ:AZN

Watchlist Manager
AstraZeneca PLC
NASDAQ:AZN
Watchlist
Price: 78.02 USD -0.37% Market Closed
Market Cap: 241.9B USD
Have any thoughts about
AstraZeneca PLC?
Write Note

AstraZeneca PLC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AstraZeneca PLC
Operating Income Peer Comparison

Comparables:
G
GSK
INDV
HIK
DPH
A
APH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
A
AstraZeneca PLC
NASDAQ:AZN
Operating Income
$10.3B
CAGR 3-Years
34%
CAGR 5-Years
19%
CAGR 10-Years
13%
G
GlaxoSmithKline PLC
NYSE:GSK
Operating Income
ÂŁ7.6B
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
2%
Indivior PLC
LSE:INDV
Operating Income
$264m
CAGR 3-Years
9%
CAGR 5-Years
-5%
CAGR 10-Years
-9%
Hikma Pharmaceuticals PLC
LSE:HIK
Operating Income
$617m
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
3%
Dechra Pharmaceuticals PLC
LSE:DPH
Operating Income
ÂŁ24.9m
CAGR 3-Years
-25%
CAGR 5-Years
-11%
CAGR 10-Years
3%
A
Alliance Pharma PLC
LSE:APH
Operating Income
ÂŁ40.8m
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
14%

See Also

What is AstraZeneca PLC's Operating Income?
Operating Income
10.3B USD

Based on the financial report for Jun 30, 2024, AstraZeneca PLC's Operating Income amounts to 10.3B USD.

What is AstraZeneca PLC's Operating Income growth rate?
Operating Income CAGR 10Y
13%

Over the last year, the Operating Income growth was 14%. The average annual Operating Income growth rates for AstraZeneca PLC have been 34% over the past three years , 19% over the past five years , and 13% over the past ten years .

Back to Top